| Literature DB >> 26801616 |
Tao Su1, Brian Chi-Yan Cheng1, Xiu-Qiong Fu1, Ting Li1, Hui Guo1, Hui-Hui Cao1, Hiu-Yee Kwan1, Anfernee Kai-Wing Tse1, Hua Yu1, Hui Cao2, Zhi-Ling Yu3,4.
Abstract
BACKGROUND: Although toxic, the Chinese medicinal herb Xanthii Fructus (XF) is commonly used to treat traditional Chinese medicine (TCM) symptoms that resemble cold, sinusitis and arthritis. According to TCM theory, stir-baking (a processing method) can reduce the toxicity and enhance the efficacy of XF.Entities:
Mesh:
Substances:
Year: 2016 PMID: 26801616 PMCID: PMC4722736 DOI: 10.1186/s12906-016-0994-3
Source DB: PubMed Journal: BMC Complement Altern Med ISSN: 1472-6882 Impact factor: 3.659
Fig. 1Cytotoxicities of XF and SBXF fractions in cultured MIHA cells. MIHA cells were treated with various concentrations of XF and SBXF fractions as indicated for 48 h, cell viability was determined by the MTT assay. All data were presented as mean ± SD. PE: petroleum; EA: ethyl acetate; n-Bu: n-butanol. *p<0.05, **p<0.01
Fig. 2Effects of XF and SBXF on NO production (a), iNOS mRNA expression levels (b) in LPS-stimulated RAW 264.7 cells. (a) Raw 264.7 cells were pretreated with LPS for 2 h, then cells were treated with XF or SBXF water extract in the presence of LPS for another 24 h. NO production was determined by the Griess reagent. (b) Raw 264.7 cells were pretreated with LPS for 2 h, then cells were treated with XF or SBXF water extract in the presence of LPS for another 18 h. iNOS mRNA expression was assessed by real-time PCR. All data were presented as mean ± SD. **p<0.01 vs. control; &&p<0.01 vs. LPS; # p<0.05, ## p<0.01 vs. XF
Fig. 3The representative negative base peak intensity (BPI) chromatograms of XF and SBXF. (a): Chemical profile of XF detected by UPLC/Q-TOF-MS analyses. (b): Chemical profile of SBXF detected by UPLC/Q-TOF-MS analyses
Compounds identified from the water extracts of XF and SBXF
| Peak no. | tR (min) | Assigned identity | Molecular | Mean measured mass (Da) | Mass accuracy (ppm) | Theoretical exact mass (Da) | Quasi-molecular ion | MS/MS m/z (ESI−) | Change trend after processing | References |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 1.368 | 1-O-caffeoylquinic acid | C16H18O9 | 353.0866 | 3.51 | 353.0873 | [M-H]− | 191 | ↓ | 24 |
| 2 | 1.593 | 3-O-caffeoylquinic acid | C16H18O9 | 353.0866 | 8.75 | 353.0873 | [M-H]− | 191;135 | ↓* | 23 |
| 3a | 2.487 | chlorogenic acid | C16H18O9 | 353.0866 | −1.35 | 353.0873 | [M-H]− | 191 | ↑** | |
| 4 | 2.546 | UN | C7H12O5 | 175.0612 | −3.78 | 175.0606 | [M-H]− | ↓ | ||
| 5 | 2.763 | 4-O-caffeoylquinic acid | C16H18O9 | 353.0866 | −6.55 | 353.0873 | [M-H]− | 173;135 | ↑* | 24 |
| 6a | 3.623 | caffeic acid | C9H8O4 | 179.0350 | 5.36 | 179.0344 | [M-H]− | ↑** | 27 | |
| 7 | 4.349 | 1,3-O-dicaffeoylquinic acid | C25H24O12 | 515.1179 | 3.05 | 515.1190 | [M-H]− | 353;299,173 | ↑ | 25,26 |
| 8 | 4.985 | UN | C25H24O13 | 531.1144 | −0.36 | 531.1131 | [M-H]− | ↓ | ||
| 9 | 6.028 | 1,4-O-dicaffeoylquinic acid | C25H24O12 | 515.1195 | 8.85 | 515.1190 | [M-H]− | 353;335;179 | ↑ | 23 |
| 10a | 6.195 | carboxyatractyloside | C31H46O18S2 | 769.2110 | 1.23 | 769.2047 | [M-H]− | ↓** | 12, 28, | |
| 11a | 6.228 | 1,5-O-dicaffeoylquinic acid | C25H24O12 | 515.1299 | −6.07 | 515.1190 | [M-H]− | 353;335;191 | ↑* | 25,26 |
| 12a | 7.03 | atractyloside | C30H46O16S2 | 725.2155 | −0.62 | 725.2149 | [M-H]− | ↑** | 28,29 | |
| 13 | 7.239 | UN | C27H46O20 | 689.2536 | −3.72 | 689.2490 | [M-H]− | ↓** | ||
| 14 | 8.032 | 4'-desulphate-atractyloside | C30H46O13S | 645.2594 | −1.05 | 645.2581 | [M-H]− | ↑** | 29 | |
| 15 | 8.575 | UN | C34H44O13 | 659.2733 | −3.57 | 659.2691 | [M-H]− | ↑* | ||
| 16 | 11.119 | UN | C19H30N4 | 313.2398 | 0.04 | 313.2386 | [M-H]− | ↓** |
*P<0.05; **P<0.01; UN unidentified
↑increased after processing procedure; ↓decreased after processing procedure
aIdentified with reference standards
Fig. 4Quantitative analyses of CATR and ATR. (a) The typical HPLC chromatograms of ten batches of XF and corresponding SBXF; (b) The contents of CATR and ATR in ten batches of XF and corresponding SBXF. CATR: Carboxyatractyloside; ATR: Atractyloside